Grünwald, Viktor http://orcid.org/0000-0003-2083-7687
Bex, Axel
Article History
First Online: 4 July 2018
Competing interests
: V.G. reports grants, personal fees and non-financial support from Bristol-Myers Squibb (BMS), grants, personal fees and non-financial support from Merck Sharp and Dohme (MSD), personal fees and non-financial support from Roche, personal fees and non-financial support from Novartis, grants and personal fees from Pfizer, grants and personal fees from AstraZeneca, personal fees from Eisai, personal fees and non-financial support from Ipsen, personal fees from EUSA Pharma and personal fees from Cerulean. A.B. reports advisory boards from Pfizer, BMS, Ipsen, Roche and Genentech. He is the principle investigator of SURTIME and received a research grant from Pfizer and the European Organisation for Research and Treatment of Cancer (EORTC).